ENO2 as a Biomarker Regulating Energy Metabolism to Promote Tumor Progression in Clear Cell Renal Cell Carcinoma

Background: Clear cell renal cell carcinoma (ccRCC) is the most common and metastatic type of renal cell carcinoma. Despite significant advancements, the current diagnostic biomarkers for ccRCC lack the desired specificity and sensitivity, necessitating the identification of novel biomarkers and elu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jian, Miao, Daojia, Lv, Qingyang, Tan, Diaoyi, Xiong, Zhiyong, Zhang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525605/
https://www.ncbi.nlm.nih.gov/pubmed/37760940
http://dx.doi.org/10.3390/biomedicines11092499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525605/
https://www.ncbi.nlm.nih.gov/pubmed/37760940
http://dx.doi.org/10.3390/biomedicines11092499

Ejemplares similares